RBC Capital analyst Keith Mackey maintained a Buy rating on Patterson-UTI (PTEN – Research Report) yesterday and set a price target of $11.00.

MD-PhD student Tomer Kagan and Dr. Tal Laviv. A novel scientific method developed at Tel Aviv University promises to ...

A new review was published in , Volume 16, on March 13, 2025, titled "Signaling pathway dysregulation in breast cancer." ...

Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Patterson-UTI Energy, Inc. (NASDAQ:PTEN – Free Report) by 32.3% during the fourth quarter, according to its most recent filing ...

The Zacks Oil and Gas - Drilling industry operates in a volatile environment, influenced by rig availability, contracting activity, and capital expenditures rather than commodity prices alone. A 5% ...

Innovations in therapeutic strategies, coupled with a deeper understanding of breast cancer biology, will be essential for advancing personalized ...

Researchers have revealed for the first time how a key protein linked to Parkinson's mutates, leads to cell death in the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ESI.TO Ensign Energy Services Inc.

After hours: March 18 at 7:49:08 PM EDT ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...